MedTrace Logo

EURAD MRI Classification of US Indeterminate Adnexa Lesions

NCT02962596 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1340

Last updated 2020-03-26

No results posted yet for this study

Summary

This research is targeting patients with sonographically indeterminate adnexal mass that are being referred for clinical MR imaging. Investigators from the UW will be contributing coded MR images and associated health information (US results, laboratory/pathology results) to the EURAD trial. In addition, outcomes data on each patient will be sent at month 24 of the research.

Conditions

  • Ovarian Tumor

Interventions

OTHER

ADNEXMR SCORING system

Scoring system used to standardize the imaging report for sonographically indeterminate adnexal masses.

Sponsors & Collaborators

  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Elizabeth Sadowski, MD · University of Wisconsin, Madison

  • Isabelle Thomassin-Naggara, MD, PhD · Assistance Publique - Hôpitaux de Paris

  • Andrea Rockall, MD · Imperial College of London

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-10-14
Completion
2018-08-15

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02962596 on ClinicalTrials.gov